Selskabets formål er drift af advokatvirksomhed med særlig fokus på ydelse af rådgivning til biotek, farmaceutisk, medicinsk anordnings-, tandlæge-, fødevare- og kosttilskud-industrierne, såvel som til disse industriers leverandører.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2 mio. | 267 t. | 7.3 mio. | 7.1 mio. | 1 | |
CVR: 30728106
Secondary names: JUSMEDICO LAW FIRM LTD ADVOKATANPARTSSELSKAB, JUSMEDICO LAW FIRM LTD ApS
Compared to 925 companies in Juridiske aktiviteter
Comparison is based on industry median values
The financial health of JUSMEDICO ADVOKATANPARTSSELSKAB appears stable, with a positive trajectory in revenue and profit over the past few years. In 2025, the company reported revenue of 1,988,499 DKK and a profit of 267,311 DKK, indicating growth from 1,648,276 DKK in revenue and 236,797 DKK in profit in 2024. However, profit margins have fluctuated, with a notable peak in 2023 at 527,871 DKK, suggesting potential volatility. The equity position has strengthened significantly, rising to 7,099,628 DKK in 2025 from 1,268,810 DKK in 2023, reflecting a solid foundation for future growth. Overall, JUSMEDICO is positioned well within the legal activities industry, although monitoring profit margins will be essential for sustained performance.
AI-generated summary
Companies in the same industry and area
CVR 37267244
CVR 36185198
CVR 19868672
CVR 42270261
CVR 32165974
EY Godkendt Revisionspartnerselskab resigned as auditor
Jan Bjerrum Bach registered with 100% ownership
companydata.dk